Halozyme Therapeutics Inc. (HALO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Halozyme Therapeutics Inc...

    NASDAQ: HALO · Real-Time Price · USD
    73.75
    -0.22 (-0.30%)
    At close: Sep 26, 2025, 3:59 PM
    73.55
    -0.27%
    After-hours: Sep 26, 2025, 07:06 PM EDT

    Halozyme Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.02B 829.25M 660.12M 443.31M
    Cost of Revenue
    		 159.42M 192.36M 139.3M 81.41M
    Gross Profit
    		 855.91M 636.89M 520.81M 361.9M
    Operating Income
    		 551.48M 337.57M 267.53M 275.9M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 557.13M 348.33M 248.92M 248.52M
    Net Income
    		 444.09M 281.59M 202.13M 402.71M
    Selling & General & Admin
    		 154.34M 149.18M 143.53M 50.32M
    Research & Development
    		 79.05M 76.36M 66.61M 35.67M
    Other Expenses
    		 71.05M 73.77M 43.15M n/a
    Operating Expenses
    		 304.43M 299.32M 253.28M 86M
    Interest Expense
    		 18.09M 18.76M 16.95M 7.53M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 463.85M 491.68M 392.58M 167.41M
    Income Tax Expense
    		 113.04M 66.73M 46.79M -154.19M
    Shares Outstanding (Basic)
    		 126.83M 131.93M 136.84M 140.65M
    Shares Outstanding (Diluted)
    		 129.42M 134.2M 140.61M 146.8M
    EPS (Basic)
    		 3.50 2.13 1.48 2.86
    EPS (Diluted)
    		 3.43 2.10 1.44 2.74
    EBITDA
    		 656.54M 451.95M 315.51M 259.04M
    EBIT
    		 575.23M 367.09M 265.87M 256.04M
    Depreciation & Amortization
    		 81.31M 84.86M 49.64M 3M

    Add to Watchlist